US7241907B2ExpiredUtilityA1
Acetone solvate of dimethoxy docetaxel and its process of preparation
Est. expirySep 19, 2023(expired)· nominal 20-yr term from priority
A61P 35/02A61P 35/00A61K 31/58C07D 305/14
88
PatentIndex Score
39
Cited by
3
References
16
Claims
Abstract
This invention discloses and claims an acetone solvate of dimethoxydocetaxel or 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxotax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and its preparation by crystallization from an aqueous/acetone solution.
Claims
exact text as granted — not AI-modified1. An acetone solvate of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxotax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate.
2. An acetone solvate of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxotax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate comprising from about 5 to about 7 percent by weight of acetone.
3. A process for the preparation of the acetone solvate of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxotax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate, which comprises:
crystallizing 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxotax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate from a mixture of water and acetone, which comprises seeding the solution with a suspension of said product in an acetone/water mixture and then subsequently treating with water, and which comprises drying the product obtained under reduced pressure.
4. The process as set forth in claim 3 , wherein the seeding is carried out at a concentration of from about 60 to about 80 g per liter of a mixture comprising an acetone/water ratio by volume of from about 65/35 to about 75/25.
5. The process as set forth in claim 4 , wherein the seeding is carried out in a mixture comprising an acetone/water ratio by volume of about 68/32.
6. The process as set forth in claim 3 , wherein the acetone/water mixture by volume at the end of precipitation is from about 70/30 to about 30/70.
7. The process as set forth in claim 6 , wherein the acetone/water mixture by volume at the end of precipitation is about 45/55.
8. The process as set forth in claim 3 , wherein the crystallization process takes place at about 20±5° C.
9. The process as set forth in claim 4 , wherein the crystallization process takes place at about 20±5° C.
10. The process as set forth in claim 5 , wherein the crystallization process takes place at about 20±5° C.
11. The process as set forth in claim 6 , wherein the crystallization process takes place at about 20±5° C.
12. The process as set forth in claim 7 , wherein the crystallization process takes place at about 20±5° C.
13. The process as set forth in claim 3 , wherein drying is carried out at a temperature in the range of from about 30 and about 60° C.
14. The process as set forth in claim 13 , wherein drying is further carried out under a pressure in the region of 0.7 kPa.
15. The process as set forth in claim 3 , wherein drying is carried out at a temperature of about 40° C. under a pressure in the region of 0.7 kPa.
16. The process as set forth in claim 3 , wherein the preparation is carried out directly starting from the acetone solution of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxotax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate obtained by deprotection in an acid medium of the ester 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxotax-11-en-13α-yl (2R,4S,5R)-3-tert-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.